<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>T. Yokota | Moulton Research Group</title><link>https://Athos213.github.io/MoultonResearchGroup/author/t.-yokota/</link><atom:link href="https://Athos213.github.io/MoultonResearchGroup/author/t.-yokota/index.xml" rel="self" type="application/rss+xml"/><description>T. Yokota</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 01 Mar 2022 00:00:00 +0000</lastBuildDate><image><url>https://Athos213.github.io/MoultonResearchGroup/media/logo_huaff08bf5787421a170f54286b3246f11_108254_300x300_fit_lanczos_3.png</url><title>T. Yokota</title><link>https://Athos213.github.io/MoultonResearchGroup/author/t.-yokota/</link></image><item><title>Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy</title><link>https://Athos213.github.io/MoultonResearchGroup/publication/pmid-35193974/</link><pubDate>Tue, 01 Mar 2022 00:00:00 +0000</pubDate><guid>https://Athos213.github.io/MoultonResearchGroup/publication/pmid-35193974/</guid><description/></item></channel></rss>